NEWS
› Novozymes Biopharma's rAlbumin approved in Japan as MAQUET expands into new market. Read more
› Novozymes Biopharma shortlisted for the Medilink UK National awards. Read more
› Novozymes Biopharma announces research agreement with EpiVax to advance pioneering treatment of autoimmune diseases. Read more
› Novozymes aligns recombinant human albumin portfolio with new brand name. Read more
EVENTS
› To view upcoming events click here